Search filters

List of works by Mathurin Fumery

Anti-TNF therapy for genital fistulas in female patients with Crohn's disease: a nationwide study from the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)

scientific article published on 07 September 2018

Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease

scientific article published on 01 August 2017

Compared efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti-TNF agent: a multicentre cohort study

scientific article published on 22 March 2020

Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease

scientific article published on 25 March 2020

Dose de-escalation to adalimumab 40 mg every three weeks in patients with inflammatory bowel disease-A multicenter, retrospective, observational study

scientific article published on 08 November 2018

Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study

scientific article published on 14 April 2020

Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis

scientific article published on 13 June 2019

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study.

scientific article published on 24 January 2017

Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD).

scientific article published on 27 October 2012

Fine-scale geographical distribution and ecological risk factors for Crohn's disease in France (2007-2014)

scientific article published on 06 October 2019

Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease: a multicentre cohort study from the GETAID

scientific article published on 26 November 2020

Letter: combination of biologics in inflammatory bowel diseases

scientific article published on 01 August 2020

Long-term outcome after first intestinal resection in pediatric-onset Crohn's disease: a population-based study

scientific article

Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis

scientific article published on 26 November 2015

Mortality and cancer in pediatric-onset inflammatory bowel disease: a population-based study

scientific article published on 13 August 2013

Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review.

scientific article

Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial

scientific article published on 27 August 2019

Postoperative Complications in Pediatric Inflammatory Bowel Disease: A Population-based Study

scientific article published on 9 September 2015

Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study

scientific article published on 07 December 2020

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents.

scientific article

Systematic review with meta-analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseases

scientific article published on 04 September 2019

Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study

scientific article published on 05 June 2019

Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies

scientific article

Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort

scientific article published on 8 December 2015

Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study

scientific article published on 01 September 2019

Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients

scientific article published on 20 February 2020